Pedro Simões

5PUBLICATIONS

41CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 10, 2026

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

|Feb 26, 2026

Assessing the Impact of Comprehensive Genomic Profiling on Therapeutic Selection for Advanced Solid Tumors in Portugal.

Nuno Tavares, Pedro Simões, Raquel Lopes-Brás

|Mar 13, 2025

Avelumab Maintenance Therapy in Advanced Urothelial Carcinoma: Implications of Timing and Treatment Sequencing.

Lisa Gonçalves, Helena Guedes, Ana Raquel Fortuna

|Oct 31, 2022

Neuroendocrine carcinoma of vagina with prolonged survival.

Luísa Leal-Costa, João Godinho, Pedro Simões

|May 25, 2022

Non-alpine primary thyroid angiosarcoma.

Nádia Mourinho Bala, Pedro Simões, José Maria Aragüés

Pageof 1

Frequent Collaborators

Diogo Alpuim Costa

Nádia Mourinho Bala

José Maria Aragüés

Ricardo Veiga

Sílvia Guerra

Cristina Valadas

Luísa Leal-Costa

Lisa Gonçalves

Ana Raquel Fortuna

Rita Freitas

Frequent Collaborators

Diogo Alpuim Costa

Nádia Mourinho Bala

José Maria Aragüés

Ricardo Veiga